17
Views
4
CrossRef citations to date
0
Altmetric
Review

Lichen sclerosus of the vulva

, , &
Pages 57-65 | Published online: 10 Jan 2014

References

  • Hallopeau H. Du lichen plan et particulièrement de sa forme atrophique: lichen plan scléreux. Ann. Dermatol. Syphiligr. 8, 790–791 (1887).
  • Weir RF. Ichthyosis of the tongue and vulva. NY State J. Med. 21, 240–256 (1875).
  • Darier J. Lichen plan scléreux. Ann. Dermatol. Syphiligr. 3, 833–837 (1892).
  • Friedrich EG. Lichen sclerosus. J. Reprod. Med. 17, 147–154 (1976).
  • Leibovitz A, Kaplun VV, Saposhnicov N, Habot B. Vulvovaginal examinations in elderly nursing home women residents. Arch. Gerontol. Geriatr. 31(1), 1–4 (2000).
  • Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J. Reprod. Med. 50(7), 477–480 (2005).
  • Wallace HJ. Lichen sclerosus et atrophicus. Trans. St. Johns. Hosp. Dermatol. Soc. 57(1), 9–30 (1971).
  • Thomas RH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. J. R. Soc. Med. 89(12), 694–698 (1996).
  • Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 353(9166), 1777–1783 (1999).
  • Lipscombe TK, Wayte J, Wojnarowska F, Marren P, Luzzi G. A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas. J. Dermatol. 38(3), 132–136 (1997).
  • Sahn EE, Bluestein EL, Oliva S. Familial lichen sclerosus et atrophicus in childhood. Pediatr. Dermatol. 11(2), 160–163 (1994).
  • Cox NH, Mitchell JN, Morley WN. Lichen sclerosus et atrophicus in non-identical female twins. Br. J. Dermatol. 115(6), 743 (1986).
  • Murphy FR, Lipa M, Haberman HF. Familial vulvar dystrophy of lichen sclerosus type. Arch. Dermatol. 118(5), 329–331 (1982).
  • Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J. Eur. Acad. Dermatol. Venereol. 24(9), 1031–1034 (2010).
  • Azurdia RM, Luzzi GA, Byren I et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br. J. Dermatol. 140(1), 79–83 (1999).
  • Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnarowska F. The association between lichen sclerosus and antigens of the HLA system. Br. J. Dermatol. 132(2), 197–203 (1995).
  • Sideri M, Rognoni M, Rizzolo L et al. Antigens of the HLA system in women with vulvar lichen sclerosus. Association with HLA-B21. J. Reprod. Med. 33(6), 551–554 (1988).
  • Gao XH, Barnardo MC, Winsey S et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J. Invest. Dermatol. 125(5), 895–899 (2005).
  • Schwartz BD. The major histocompatibility complex and disease susceptibility. In: Cecil Textbook of Medicine. Wyngaarden JB, Smith LH Jr, Bennet JC (Eds). Saunders, PA, USA, 1470–1479 (1992).
  • Clay FE, Cork MJ, Tarlow JK et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum. Genet. 94(4), 407–410 (1994).
  • Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case–control study. Arch. Dermatol. 144(11), 1432–1435 (2008).
  • Higgins CA, Cruickshank ME. A population-based case–control study of aetiological factors associated with vulval lichen sclerosus. J. Obstet. Gynaecol. 32(3), 271–275 (2012).
  • Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br. J. Dermatol. 142(3), 481–484 (2000).
  • Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br. J. Dermatol. 104(5), 563–566 (1981).
  • Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br. J. Dermatol. 109(6), 661–664 (1983).
  • Lukowsky A, Muche JM, Sterry W, Audring H. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-β polymerase chain reaction assays. J. Invest. Dermatol. 115(2), 254–259 (2000).
  • Regauer S, Reich O, Beham-Schmid C. Monoclonal β-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am. J. Pathol. 160(3), 1035–1045 (2002).
  • Carlson JA, Grabowski R, Chichester P, Paunovich E, Malfetano J. Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous – implications for pathogenesis. Am. J. Dermatopathol. 22(1), 7–16 (2000).
  • Bracco GL, Carli P, Sonni L et al. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J. Reprod. Med. 38(1), 37–40 (1993).
  • Chan I, Oyama N, Neill SM, Wojnarowska F, Black MM, McGrath JA. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin. Exp. Dermatol. 29(5), 499–504 (2004).
  • Gambichler T, Skrygan M, Czempiel V et al. Differential expression of connective tissue growth factor and extracellular matrix proteins in lichen sclerosus. J. Eur. Acad. Dermatol. Venereol. 26(2), 207–212 (2012).
  • Friedrich EG Jr, Kalra PS. Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone. N. Engl. J. Med. 310(8), 488–491 (1984).
  • Kohlberger PD, Joura EA, Bancher D, Gitsch G, Breitenecker G, Kieback DG. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J. Soc. Gynecol. Investig. 5(6), 331–333 (1998).
  • Hodgins MB, Spike RC, Mackie RM et al. Immunohistochemisty of steroid receptors in vagina and vulvar skin: evidence for loss of androgen and estrogen receptor in the lesional epidermis of vulvar lichen sclerosus. Br. J. Dermatol. 125, 486–491 (1991).
  • Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J. Reprod. Med. 40(5), 351–354 (1995).
  • Neill SM, Lewis FM, Tatnall FM, Cox NH; British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br. J. Dermatol. 163(4), 672–682 (2010).
  • Boulinguez S, Bernard P, Lacour JP et al. Bullous lichen sclerosus with chronic hepatitis C virus infection. Br. J. Dermatol. 137(3), 474–475 (1997).
  • Cantwell AR Jr. Histologic observations of pleomorphic, variably acid-fast bacteria in scleroderma, morphea, and lichen sclerosus et atrophicus. Int. J. Dermatol. 23(1), 45–52 (1984).
  • Drut RM, Gómez MA, Drut R, Lojo MM. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr. Dermatol. 15(2), 85–90 (1998).
  • Karram M, Tabor B, Smotkin D, Wettstein F, Bhatia N, Micha J. Detection of human papillomavirus deoxyribonucleic acid from vulvar dystrophies and vulvar intraepithelial neoplastic lesions. Am. J. Obstet. Gynecol. 159(1), 22–23 (1988).
  • Neill SM, Lessana-Leibowitch M, Pelisse M, Moyal-Barracco M. Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus. Am. J. Obstet. Gynecol. 162(6), 1633–1634 (1990).
  • Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br. J. Dermatol. 142(4), 636–644 (2000).
  • Val I, Almeida G. An overview of lichen sclerosus. Clin. Obstet. Gynecol. 48(4), 808–817 (2005).
  • Murphy R. Lichen sclerosus. Dermatol. Clin. 28, 707–715 (2010).
  • Smith YR, Haefner HK. Vulvar lichen sclerosus: pathophysiology and treatment. Am. J. Clin. Dermatol. 5(2), 105–125 (2004).
  • Günthert AR, Duclos K, Jahns BG et al. Clinical scoring system for vulvar lichen sclerosus. J. Sex. Med. 9(9), 2342–2350 (2012).
  • Hewitt J. Histologic criteria for lichen sclerosus of the vulva. J. Reprod. Med. 31(9), 781–787 (1986).
  • Regauer S, Liegl B, Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 47(4), 340–347 (2005).
  • Funaro D. Lichen sclerosus: a review and practical approach. Dermatol. Ther. 17(1), 28–37 (2004).
  • Tausch TJ, Peterson AC. Early aggressive treatment of lichen sclerosus may prevent disease progression. J. Urol. 187(6), 2101–2105 (2012).
  • LeFevre C, Hoffstetter S, Meyer S, Gavard J. Management of lichen sclerosus with triamcinolone ointment: effectiveness in reduction of patient symptom scores. J. Low. Genit. Tract Dis. 15(3), 205–209 (2011).
  • Goldstein AT, Creasey A, Pfau R, Phillips D, Burrows LJ. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J. Am. Acad. Dermatol. 64(6), e99–e104 (2011).
  • Schwegler J, Schwarz J, Eulenburg C et al. Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva. Dermatology (Basel) 223(2), 152–160 (2011).
  • Ventolini G, Swenson KM, Galloway ML. Lichen sclerosus: a 5-year follow-up after topical, subdermal, or combined therapy. J. Low. Genit. Tract Dis. 16(3), 271–274 (2012).
  • Cinberg BL. Postmenopausal pruritis vulvae. Am. J. Obstet. Gynecol. 49, 647–657 (1945).
  • Friedrich EG Jr. Topical testosterone for benign vulvar dystrophy. Obstet. Gynecol. 37(5), 677–686 (1971).
  • Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int. J. Gynaecol. Obstet. 46(1), 53–56 (1994).
  • Origoni M, Garsia S, Sideri M, Pifarotti G, Nicora M. Efficacy of topical oxatomide in women with pruritus vulvae. Drugs Exp. Clin. Res. 16(11), 591–596 (1990).
  • Origoni M, Ferrari D, Rossi M, Gandini F, Sideri M, Ferrari A. Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus. Int. J. Gynaecol. Obstet. 55(3), 259–264 (1996).
  • Bousema MT, Romppanen U, Geiger JM et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J. Am. Acad. Dermatol. 30(2 Pt 1), 225–231 (1994).
  • Virgili A, Corazza M, Bianchi A, Mollica G, Califano A. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. J. Reprod. Med. 40(9), 614–618 (1995).
  • Hengge UR, Krause W, Hofmann H et al. Multicentre, Phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br. J. Dermatol. 155(5), 1021–1028 (2006).
  • Boms S, Gambichler T, Freitag M, Altmeyer P, Kreuter A. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. BMC Dermatol. 4(1), 14 (2004).
  • Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst. Rev. 12, CD008240 (2011).
  • Tennis P, Gelfand JM, Rothman KJ. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br. J. Dermatol. 165(3), 465–473 (2011).
  • Hillemanns P, Untch M, Pröve F, Baumgartner R, Hillemanns M, Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet. Gynecol. 93(1), 71–74 (1999).
  • August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br. J. Dermatol. 103(6), 667–670 (1980).
  • Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br. J. Dermatol. 136(3), 356–359 (1997).
  • Jones RW, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am. J. Obstet. Gynecol. 198(5), 496.e1–e3 (2008).
  • Brisigotti M, Moreno A, Murcia C, Matías-Guiu X, Prat J. Verrucous carcinoma of the vulva. A clinicopathologic and immunohistochemical study of five cases. Int. J. Gynecol. Pathol. 8(1), 1–7 (1989).
  • Meyrick-Thomas RH, Mc Gibbon DH, Munro DD. Basal cell carcinoma of the vulva in association with vulval lichen sclerosus et atrophicus. J. R. Soc. Med. 78, 16–18 (1985).
  • Friedman RJ, Kopf AW, Jones WB. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. Am. J. Dermatopathol. 6(Suppl.), 253–256 (1984).
  • Carlson JA, Amin S, Malfetano J et al. Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus. Appl. Immunohistochem. Mol. Morphol. 9(2), 150–163 (2001).
  • Rolfe KJ, Crow JC, Benjamin E, Reid WM, Maclean AB, Perrett CW. Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions. Int. J. Gynecol. Cancer 11(5), 381–386 (2001).
  • MacLean AB, Reid WM, Rolfe KJ et al. Role of angiogenesis in benign, premalignant and malignant vulvar lesions. J. Reprod. Med. 45(8), 609–612 (2000).
  • Jones RW, Sadler L, Grant S, Whineray J, Exeter M, Rowan D. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case–control study. J. Reprod. Med. 49(10), 808–811 (2004).
  • Doldi N, Origoni M, Bassan M, Ferrari D, Rossi M, Ferrari A. Vascular endothelial growth factor. Expression in human vulvar neoplastic and non-neoplastic tissues. J. Reprod. Med. 41(11), 844–848 (1996).
  • Vanin K, Scurry J, Thorne H, Yuen K, Ramsay RG. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. J. Invest. Dermatol. 119(5), 1027–1033 (2002).
  • Laymon CW. Lichen sclerosus et atrophicus in childhood. Arch. Derm. Syphilol. 52, 351–353 (1945).
  • Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J. Am. Acad. Dermatol. 44(5), 803–806 (2001).
  • Clark JA, Muller SA. Lichen sclerosus et atrophicus in children. A report of 24 cases. Arch. Dermatol. 95(5), 476–482 (1967).
  • Ridley CM. Genital lichen sclerosus (lichen sclerosus et atrophicus) in childhood and adolescence. J. R. Soc. Med. 86(2), 69–75 (1993).
  • Smith SD, Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr. Dermatol. 26(6), 725–729 (2009).
  • Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan. Med. J. 59(5), A4424 (2012).
  • Poindexter G, Morrell DS. Anogenital pruritus: lichen sclerosus in children. Pediatr. Ann. 36(12), 785–791 (2007).
  • Smith SD, Fischer G. Paediatric vulval lichen sclerosus. Australas. J. Dermatol. 50(4), 243–248 (2009).
  • Patrizi A, Gurioli C, Medri M, Neri I. Childhood lichen sclerosus: a long-term follow-up. Pediatr. Dermatol. 27(1), 101–103 (2010).
  • Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch. Dermatol. 140(6), 702–706 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.